Madrigal Pharmaceuticals, Inc. (MDGL)
513.39
-0.08
(-0.02%)
USD |
NASDAQ |
May 21, 16:00
513.39
0.00 (0.00%)
After-Hours: 19:59
Madrigal Pharmaceuticals Research and Development Expense (TTM) : 451.53M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 828.00M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| PTC Therapeutics, Inc. | 447.15M |
| Protagonist Therapeutics, Inc. | 170.14M |
| Altimmune, Inc. | 66.69M |